Shareholders of HeartSciences Inc., a Texas heart-diagnostics company listed on Nasdaq under the ticker HSCS, approved on Thursday 19 November 2026 a merger that would turn their company into Fortitude blockchain and earns a reward, which makes rewriting history very expensive.">Mining Group, the Zcash miner owned by Digital Currency Group (DCG). The count is in a Form 8-K filed with the SEC the same day: 3,480,989 shares voted for the merger agreement, 20,933 against and 3,150 abstained. The Fortitude Zcash miner is not listed yet. Nasdaq still has to approve the combined company under its initial-listing standards, and no closing date has been set.
The vote was not one by Fortitude’s own shareholders, as some headlines suggested. Fortitude has a single owner, DCG, which signed its consent on 23 June 2026, the day the merger agreement was dated. The people who voted on Thursday were the holders of a small medical-technology stock, and what they agreed to is a reverse merger: their listed company takes in a much larger private business and comes out with a new name, a new majority owner and a planned new ticker, TUDE.
What HeartSciences shareholders approved on 19 November
According to the 8-K, 5,292,799 votes could be cast at the special meeting: 4,949,283 common shares outstanding on the record date of 8 October, plus 343,516 shares that the Series C preferred stock converts into. Holders of 4,041,647 of them, or 76.36%, took part online or by proxy, enough for a quorum.
The merger proposal needed more than a simple majority of those present. The definitive proxy statement of 19 October sets the bar at a majority of all shares issued and outstanding, so that an abstention or a share left unvoted counted as a vote against. The 3,480,989 votes in favour are 86.1% of the shares present and 65.8% of all shares entitled to vote by arithmetic on the 8-K’s own counts. Fortitude’s release of Friday 20 November speaks of “approximately 86%” of the votes: that is the first of those two numbers, with the 536,575 broker non-votes counted among the shares present.
| Proposal | For | Against | Abstained |
|---|---|---|---|
| 1. Merger agreement with Fortitude | 3,480,989 | 20,933 | 3,150 |
| 2. Share issuances and change of control under Nasdaq Rule 5635 | 3,459,400 | 43,445 | 2,228 |
| 3A. New name, Fortitude Mining Group, Inc. | 3,987,307 | 39,842 | 14,496 |
| 3D. Creation of Class V common stock | 3,377,858 | 42,552 | 84,662 |
| 4. Reverse stock split, between 1-for-2 and 1-for-5 | 3,981,498 | 40,735 | 19,411 |
Source: HeartSciences Form 8-K, Item 5.07, filed on 19 November 2026. Broker non-votes, 536,575 on the merger proposal, are not shown.
The second proposal is wider than its title. Besides the shares issued to DCG’s side, it lets the combined company sell or exchange up to 35,000,000 more Class A shares within one month of closing, for cash, Zcash or the cancellation of debt worth no more than $100,000,000 in total, at a discount of up to 20% to the market price. The fourth gives the board the option of a reverse stock split at a ratio it will agree with Fortitude. The proxy says the main purpose of that split is to lift the share price above the minimum bid that Nasdaq requires for an initial listing.
HeartSciences opened another door to new shares on the eve of the meeting. A separate 8-K filed on 19 November says it signed an agreement with Maxim Group on 18 November to sell up to $50,000,000 of common stock “at the market”, although SEC limits on small companies mean the prospectus supplement covers only $3,077,649 for now. Shares sold that way before closing are not in the proxy’s arithmetic: the exchange ratio applies to a count fixed in the merger agreement (3,290,350 shares outstanding at signing, plus preferred conversions, stock units and pre-funded warrants), and the ownership illustration is given without the effect of any permitted share issue before closing.
The meeting did not go unchallenged. In an 8-K of 6 November, HeartSciences said it had received seven demand letters from lawyers for purported shareholders, who alleged that the proxy left out material information. The company called the allegations “without merit” and published supplemental disclosures anyway.
How the reverse merger works, and what an HSCS holder is left with
In a reverse merger, a private company goes public by combining with a company that already has a stock-exchange listing, instead of selling new shares in an initial public offering. The listed company is legally the buyer. In substance it is the one being taken over, because it pays with so many new shares that the private company’s owner ends up in control. The proxy states that the deal will be accounted for as a reverse acquisition.
Here the structure is an “Up-C”, a two-level arrangement. Fortitude’s mining business will sit in a limited liability company, Fortitude HoldCo, managed by the listed company. DCG’s vehicle, Fortitude Mining Holdings, receives two things. The first is a block of new Class V shares, which carry one vote each and no economic rights, and which will not be listed. The second is a matching number of non-voting units in the limited liability company, which hold the economic interest and which the proxy describes as intended to be economically equivalent to Class A shares.
The number of Class V shares is set by a fixed exchange ratio: 19.00 for each HeartSciences share counted at closing, or 21.22 if the stock’s volume-weighted average price over the 20 business days ending two days before closing is $7.50 or more. HeartSciences closed at $3.02 on 16 October, the last price given in the proxy. Fortitude Mining Holdings also puts in $2,000,000, in cash or in Zcash, for Class A shares priced at that average. Its 20 November release says it expects to pay in ZEC, possibly supplied by DCG, and expects the combined company to sell those coins to cover closing costs. It already owns 411,522 HeartSciences shares, bought for about $1.0 million at $2.43 each in a private placement on 12 August.
An existing HSCS holder is not paid anything and does not swap shares. The shares stay in the account, are renamed Class A common stock, may be consolidated by the reverse split, and would trade under TUDE if Nasdaq approves the listing (the warrants would become TUDEW). What changes is the size of the slice. In the proxy’s illustration, based on share counts at 8 October and an assumed average price of $4.29, the combined company would have about 7.68 million Class A shares and about 107.41 million Class V shares. DCG’s side would hold about 94% of the votes and the other HeartSciences holders about 6%. Two rounder figures sit elsewhere in the same document: the split first proposed in a December 2025 letter of intent was 95% to 5%, a note to Fortitude’s financial statements still says “approximately 95%”, and the fairness opinion tested a 5.0% stake. The 94% and 6% of the illustration are the proxy’s most detailed count.

Control comes with consequences the proxy spells out. The combined company will be a “controlled company” under Nasdaq rules and intends to use the exemptions from some governance requirements that this status allows. Its board is expected to have nine members, seven of them designated by DCG. The 20 November release names two of the seven, both as independent directors: Elizabeth B. Higgins, finance chief of Oglethorpe Power, and Simcha Wurtzel, a former principal financial officer of Grayscale. Class A holders, voting alone, elect one director. The heart-diagnostics business, including the MyoVista device, moves into a subsidiary.
The only valuation in the filings is a fairness-opinion range
Neither the 8-K nor the proxy puts a market value on Fortitude. The one figure available comes from the fairness opinion that Houlihan Capital wrote for a special committee of the HeartSciences board: an indicated equity value for Fortitude alone of $206.0 million to $428.2 million. It was obtained by applying multiples of 2.0 to 5.0 times revenue and 10 times forecast 2027 EBITDA, chosen after a look at seven listed miners, and it reflects market conditions as of 16 June 2026. Houlihan itself notes that those peers are mostly bitcoin miners and that none is directly comparable to a company concentrated on Zcash. The range is an adviser’s estimate made to judge whether a 5.0% stake was fair to HeartSciences holders, not a price anyone has paid.
Three things still stand between the vote and a TUDE listing
The first is Nasdaq. Because the exchange treats the deal as a change of control, the renamed company must meet the initial-listing standards, which the proxy calls “more difficult to achieve” than the continued-listing rules HeartSciences lives under now. Written confirmation from Nasdaq is a condition of closing. The proxy says the parties are not expected to waive it, and that without it the transactions will not be completed.
The second is the rest of the closing conditions: no court order blocking the merger, the expiry of any antitrust waiting period under the Hart-Scott-Rodino Act, the conversion of HeartSciences’ preferred shares, and no material adverse change at either company. The proxy said closing was “anticipated” in the fourth quarter of 2026 and added that the timing could not be predicted. Fortitude’s release of 20 November gives no date either: it says only that the remaining conditions, Nasdaq’s approval among them, still have to be met.
The third is time. Section 9.01(b)(iii) of the merger agreement lets either side walk away if the merger has not closed by the “End Date”, defined as seven months after the date of the agreement. The agreement is dated 23 June 2026, which puts that date at 23 January 2027. The 23 January date is arithmetic from that clause; the filing does not print a calendar date. A second deadline sits just behind it. HeartSciences’ shareholders’ equity was below the $2.5 million Nasdaq minimum at 30 April, and the exchange has given it until 1 February 2027 to show compliance, on a plan that consists of completing this merger.
Fortitude’s Zcash mining business in the proxy’s numbers
Fortitude was spun out of Foundry, DCG’s mining-services subsidiary, in October 2024, and its team has run Zcash machines since 2019. Zcash is mined with proof of work, like bitcoin, but on a different algorithm, Equihash, which needs its own specialised machines. The proxy counts more than 60 megawatts of capacity at seven company-operated sites in South Dakota, Nebraska, Texas and New York, including a 12-megawatt site at Grand Island, Nebraska, switched on in July 2026 with an estimated power cost of about $0.045 per kilowatt-hour.
Each figure below belongs to the period shown next to it; the proxy does not give all of them for the same dates.
| Measure | Figure | Period or date |
|---|---|---|
| ZEC mined | 72,707 (124,025 a year earlier, down 41%) | Six months to 30 June 2026 |
| ZEC mined | About 90,582 | Nine months to 30 September 2026 |
| Share of Zcash network hashrate (company estimate) | About 21.5% | Nine months to 30 September 2026 |
| Average deployed hashrate | 4.10 GSol/s (3.77 a year earlier) | Six months to 30 June 2026 |
| Average ZEC market price / average selling price | $368 / $336 | Six months to 30 June 2026 |
| ZEC held | 2,956 ZEC, fair value about $1.2 million | 30 June 2026 |
| Total revenue | $40.1 million ($40.8 million a year earlier) | Six months to 30 June 2026 |
| Net loss | $14.2 million | Six months to 30 June 2026 |
| Revenue from Foundry’s pools | About 70% of revenue | Six months to 30 June 2026 |
Source: HeartSciences definitive proxy statement (DEFM14A), filed on 19 October 2026.
Two of those lines pull in opposite directions. The average price of ZEC rose from $40 to $368 between the first half of 2025 and the first half of 2026, and Fortitude ran more machines. Yet it mined 41% fewer coins, because the network’s total hashrate, which the proxy puts at about 12 to 21 GSol/s during the half, grew faster than its own. The company writes that its share of the network declined over that period. Subtracting the six-month total from the nine-month one leaves about 17,900 ZEC for the third quarter, a figure the proxy does not print itself.
The first-half loss includes a $10.3 million impairment on bitcoin and other non-Zcash machines and $4.3 million of transaction costs. For the full year 2025, the net loss was $12.7 million.
Fortitude is buying its way back up. It ordered 9,000 Bitmain Antminer Z15 Pro machines in May 2026 for about $31.5 million, paid in full, with 3,000 due to ship in October and 6,000 in November. The proxy estimates they add about 7.56 GSol/s. The company’s 20 November release says its Zcash operating hashrate now exceeds 5.4 GSol/s. In the same release, chief executive Jaime Leverton, the former Hut 8 boss who took over on 21 September, said the vote would let Fortitude become “a premier publicly traded Zcash mining platform”.

The risks the filing itself lists: one pool, one supplier, one coin
The smart contract holding reserves of two or more tokens, supplied by users, that a decentralized exchange uses to execute trades automatically at a price set by a formula.">pool that pays Fortitude belongs to its parent. At 30 September, substantially all of its Zcash hashrate pointed at Foundry’s Zcash pool, where Fortitude alone supplied about 97.75% of the pool’s power. A risk factor warns that this concentration of revenue with one counterparty is magnified because the counterparty is a related party. Another notes that only one manufacturer, Bitmain, can supply Zcash machines at scale.
A third DCG company enters at closing. Grayscale is due to sign a ten-year agreement to manage Fortitude’s digital assets for a fee of 1.0% of their value a year, with custody at BitGo and Coinbase. Coindaro covered Grayscale’s $1 million Zcash pledge earlier this month.
Then there is the question a ZEC holder will ask: what happens to the coins? The 20 November release, like the additional proxy material filed the day before, repeats a sentence from the proxy: “Fortitude currently sells or otherwise monetizes all the digital assets that it mines, including ZEC.” It adds that Fortitude and its affiliates, DCG included, sell or pledge their holdings from time to time. The 2,956 ZEC on the balance sheet at 30 June reflected, in the company’s words, a decision to retain more of what it mined, and a risk factor leaves open a future treasury strategy of holding or buying Zcash. No holdings figure has been published for any later date.
The filing also lists what could hurt a business tied to one privacy coin: a fall in the ZEC price, rising network difficulty, and the possibility that trading venues restrict the asset. It cites Coinbase removing Zcash from its UK platform in August 2019. European readers saw a recent reminder of how awkward the asset can be for regulated markets when Euronext suspended a Zcash exchange-traded product on its first day.
Where ZEC stood around the vote
ZEC traded at $769.88 on Coinbase at 12:18 UTC on Saturday 21 November. On Friday 20 November, the day Fortitude announced the result (its release is stamped 07:30 New York time, 12:30 UTC), Coinbase’s daily candle (UTC) shows an open of $892.67, a low of $724.21 and a close of $758.69. The highest daily price on the exchange since 1 September was $1,693.20, on 26 September. At Saturday’s price, the 2,956 ZEC that Fortitude held at 30 June would be worth about $2.28 million (arithmetic on the June balance; the current one is not public). None of the filings or reports cited here connects Friday’s price move to the vote.
The protocol that Fortitude mines is also changing under it. The proxy, written before the upgrade, describes the community vote that kept Zcash’s halving schedule and cut block times from 75 to 25 seconds. Coindaro has covered the activation of that NU7 upgrade and the later draft proposal for 20-second blocks. For how a miner’s share of a network is measured, see our guide to hashrate and difficulty, written for bitcoin but built on the same mechanism.
What to watch next
The next document to look for is an 8-K from HeartSciences announcing either Nasdaq’s decision on the initial-listing application or the closing itself, along with the ratio chosen for the reverse split. Until then the stock keeps trading as HSCS. If the merger closes, the first quarterly report of Fortitude Mining Group will show for the first time how much ZEC the company holds after a period in which it says it sells what it mines. The dates that bound all of this are 23 January 2027 for the merger agreement and 1 February 2027 for HeartSciences’ own standing with Nasdaq.
